<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>21</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="epublish">
        <Year>2022</Year>
        <Month>10</Month>
        <Day>26</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association of Gene Polymorphisms in CXC Chemokine Receptor 5 with Rheumatoid Arthritis Susceptibility</title>
    <FirstPage>537</FirstPage>
    <LastPage>548</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zhenzhen</FirstName>
        <LastName>Su</LastName>
        <affiliation locale="en_US">Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China</affiliation>
      </Author>
      <Author>
        <FirstName>Lin</FirstName>
        <LastName>Chen</LastName>
        <affiliation locale="en_US">Department of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, Sichuan, China</affiliation>
      </Author>
      <Author>
        <FirstName>Qian</FirstName>
        <LastName>Niu</LastName>
        <affiliation locale="en_US">Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China</affiliation>
      </Author>
      <Author>
        <FirstName>Bin</FirstName>
        <LastName>Yang</LastName>
        <affiliation locale="en_US">Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China</affiliation>
      </Author>
      <Author>
        <FirstName>Zhuochun</FirstName>
        <LastName>Huang</LastName>
        <affiliation locale="en_US">Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>10</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>07</Month>
        <Day>06</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Rheumatoid arthritis (RA) is caused by complicated interactions between genes and the environment. CXC chemokine receptor 5 (CXCR5) is required for B and T follicular helper cell migration and humoral immunity generation. Therefore, this study aimed to assess whether polymorphisms of the CXCR5 gene are implicated in RA development and progression.
This case-control study enrolled 285 RA patients and 291 healthy controls. The polymerase chain reaction-ligase detection reaction method was used to genotype rs630923, rs497916, rs3922, and rs676925 in the CXCR5 gene. Epidemiological, clinical, and laboratory data were collected retrospectively.
The rs630923 A allele was associated with a higher risk of RA (AOR [adjusted odds ratio]=2.00, 95% confidence interval [CI] =1.14&#x2013;3.53). However, in the RA group, the frequency of the rs497916 T allele was lower (AOR=0.69, 95% CI=0.51&#x2013;0.93). Regarding rs3922, AG+GG genotype carriers were at a significantly lower risk for RA than AA genotype carriers (AOR=0.70, 95% CI=0.49&#x2013;0.99). In the RA group, we found that the different genotypes were significantly associated with specific laboratory values, including rheumatoid factor, total bilirubin, total cholesterol, low-density lipoprotein cholesterol, and alkaline phosphatase.
This is the first report indicating that CXCR5 polymorphisms were associated with RA susceptibility. These findings lead to a rising possibility of identifying RA-susceptible individuals based on genetic markers.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/3390</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/3390/1881</pdf_url>
  </Article>
</Articles>
